Effect of Nicotinic Acid in Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial
Condition: Migraine Prophylaxis Interventions: Drug: Nicotinic Acid 500 MG Extended Release Oral Tablet; Drug: Nicotinic Acid 1000 MG Extended Release Oral Tablet; Other: Placebo Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials
Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation
Conditions: Healthy; Skin Manifestations Interventions: Dietary Supplement: Probiotic with niacin and berry extract; Dietary Supplement: Probiotic without niacin and berry extract; Dietary Supplement: Placebo Sponsor: Oriflame Cosmetics AB Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2022 Category: Research Source Type: clinical trials
